Persing, David H.
Cepheid (United States)
6 papers on CoChat
Most cited papers
- Verified
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine
Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis
Cited by 2,309
- Verified
Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology
Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis
Cited by 914
- Verified
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
Chakravorty, S., Simmons, A. M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., Banada, P. P., Deshpande, S., Shenai, S., Gall, A., et al. (2017) · mBio
Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis
Cited by 668
- Verified
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease
Fort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., et al. (2005) · The Journal of Immunology
Immune Response and InflammationInflammatory Bowel Disease
Cited by 216
- Verified
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine
Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis
Cited by 118
- Verified
Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study
Kuhn, L., Saidu, R., Boa, R., Tergas, A., Moodley, J., Persing, D., Campbell, S., Tsai, W.-Y., Wright, T. C., & Denny, L. (2020) · The Lancet Global Health
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free